P3 Health Partners Inc（PIII）價格預測PIIIP3 Health Partners Inc

Alphio's PIII stock price prediction model matches the current P3 Health Partners Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.03 (+0.42%). The 1-week path is $3.99 (-0.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

P3 Health Partners Inc. appears to be a good buy right now due to its recent turnaround in profitability, reporting a net income of $15.7 million in Q2 2026, a significant recovery from a loss of $43.7 million the previous year. Additionally, the stock is currently priced at $4.01, which is significantly lower than its 52-week high of $16.89, suggesting potential for upside. The forward P/E ratio is at 0, indicating that the stock is undervalued based on future earnings expectations. However, the main risk lies in its current debt situation, with a debt-to-equity ratio of 94.64%, which could impact financial stability if not managed properly.

P3 Health Partners Inc (PIII) last closed at $4.0100002, gaining +4.97%. These facts feed the 1-day and 1-week PIII price prediction above.